Stockholders' Equity

3 Months Ended

Jun. 30, 2022

Stockholders' Equity Note [Abstract]

Stockholders' Equity

Stockholders' Equity

Stock Repurchase Program. The Company's Board of Directors has approved various authorizations under the Company's stock repurchase program to repurchase shares of its common stock (collectively, the stock repurchase program). The stock repurchase program does not obligate the Company to acquire any amount of common stock and may be suspended at any time at the Company's discretion. As of June 30, 2022, the aggregate remaining approved amount under the stock repurchase program is $354,014.

Stock repurchase activity under the Company's stock repurchase program during the three months ended June 30, 2022, was as follows:

	Amounts
Total number of shares repurchased*	384,413
Average price paid per share	$	260.12
Dollar value of shares repurchased**	$	99,993

*All stock repurchases were made pursuant to the Company's publicly announced stock repurchase program in open-market transactions.

** May not calculate on rounded dollars.

Subsequent to June 30, 2022, through July 14, 2022, the Company repurchased 68,674 shares at an average price of $262.09 per share for $17,999 and had $336,015 remaining authorized under the stock repurchase program. Refer to Note 12, “Subsequent Events,” for further information on the approval of an additional stock repurchase authorization.

Accumulated Other Comprehensive Loss. The components within AOCL recorded in the condensed consolidated balance sheets are as follows:

	June 30, 2022		March 31, 2022
Unrealized gain on cash flow hedges, net of tax	$	758	$	—
Cumulative foreign currency translation loss	(40,679)		(24,955)
Total	$	(39,921)	$	(24,955)